Skip to main content


Page 10 of 12

  1. Recent studies provide evidence of improved clinical benefits associated with cardiac resynchronization therapy (CRT) optimization. Our analysis explores the cost-effectiveness of systematically optimized (SO,...

    Authors: Kurt Banz, Peter Paul Delnoy and Jean Renaud Billuart
    Citation: Health Economics Review 2015 5:19
  2. Health authorities are constantly searching for new ways to stabilise health expenditures. To explore this issue, we compared the costs generated by different types of medical practice in French general medici...

    Authors: Aurélie Colas, Karine Danno, Cynthia Tabar, Jenifer Ehreth and Gérard Duru
    Citation: Health Economics Review 2015 5:18
  3. Apixaban, a novel oral anticoagulant which has been approved for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation, reduces both ischemic and haemorrhagic stroke and produces f...

    Authors: Mariano Anibal Giorgi, Christian Caroli, Norberto Damian Giglio, Paula Micone, Eleonora Aiello, Cristina Vulcano, Julia Blanco, Bonnie Donato and Joaquin Mould Quevedo
    Citation: Health Economics Review 2015 5:17
  4. In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calcium-based phosphate binders (CB). However, their use is associated with vascular calcification and an inc...

    Authors: Blanca Gros, Antonio Galán, Emilio González-Parra, Jose A Herrero, Maria Echave, Stefan Vegter, Keith Tolley and Itziar Oyagüez
    Citation: Health Economics Review 2015 5:14
  5. Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA) and have less gastrointestinal ...

    Authors: Sherif A Nasef, A. Aziz Shaaban, Joaquin Mould-Quevedo and Tarek A Ismail
    Citation: Health Economics Review 2015 5:13
  6. The use of subgroups based on biological-clinical and socio-demographic variables to deal with population heterogeneity is well-established in public policy. The use of subgroups based on preferences is rare, ...

    Authors: Mette Kjer Kaltoft, Robin Turner, Michelle Cunich, Glenn Salkeld, Jesper Bo Nielsen and Jack Dowie
    Citation: Health Economics Review 2015 5:10
  7. This article examines young people's preferences for integrated family planning (FP) and HIV services in rural Malawi. Different hypothetical configurations for outreach services are presented using a Discrete...

    Authors: Christine Michaels-Igbokwe, Mylene Lagarde, John Cairns and Fern Terris-Prestholt
    Citation: Health Economics Review 2015 5:9
  8. Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the ...

    Authors: Alexander Kuhlmann, Marina Treskova, Sebastian Braun and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2015 5:7
  9. Heavy episodic (“binge”) drinking of alcohol has serious public health implications, especially for youth and young adults. Previous summaries and surveys have failed to address in a comprehensive manner the e...

    Authors: Jon P Nelson
    Citation: Health Economics Review 2015 5:6

    The Letter to Editor to this article has been published in Health Economics Review 2016 6:4

  10. Recently, Nigeria emerged as the largest economy in Africa and the 26th in the world. However, a pertinent question is how this new economic status has impacted on the wealth and health of her citizens. There ...

    Authors: Adeniyi F Fagbamigbe, Elijah A Bamgboye, Bidemi O Yusuf, Joshua O Akinyemi, Bolakale K Issa, Evelyn Ngige, Perpetua Amida, Adebobola Bashorun and Emmanuel Abatta
    Citation: Health Economics Review 2015 5:5
  11. The medical record is a repository of clinical data, which can greatly enhance the quality of health and healthcare analysis. Administrative data are collected for the purpose of billing and reimbursement, and...

    Authors: David Rowell, Louisa G Gordon, Catherine M Olsen and David C Whiteman
    Citation: Health Economics Review 2015 5:4
  12. South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable differences in mix of public and private sector expenditure on health. This study intends to estimate...

    Authors: Jahangir AM Khan and Rashidul Alam Mahumud
    Citation: Health Economics Review 2015 5:3
  13. This article aims to assess the relationship between the monetary value of informal care - approximated with the caregiver's willingness to pay to reduce caregiving time - and the caregiver's need of three typ...

    Authors: Chloé Gervès-Pinquié, Martine M Bellanger and Joel Ankri
    Citation: Health Economics Review 2014 4:34
  14. Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal...

    Authors: Andrea Lebioda, David Gasche, Franz-Werner Dippel, Karlheinz Theobald and Stefan Plantör
    Citation: Health Economics Review 2014 4:31
  15. To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany.

    Authors: Sarah Neubauer, Mary Cifaldi, Thomas Mittendorf, Arijit Ganguli, Malte Wolff and Jan Zeidler
    Citation: Health Economics Review 2014 4:32
  16. EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that has received attention is the selection of the states for direct valuation by respondents. Changes in the valua...

    Authors: Henry Bailey, Paul Kind and Althea La Foucade
    Citation: Health Economics Review 2014 4:29
  17. Diabetes Mellitus Type II (T2DM) is a major and growing medical, social and economic burden in the East-Asian country of Cambodia. However, no economic modelling has been done to predict the number of cases an...

    Authors: Steffen Flessa and Anika Zembok
    Citation: Health Economics Review 2014 4:24
  18. The aim of this study is to estimate the cost of care and treatment for extremely low birth weight (ELBW) neonates admitted to a teaching and referral hospital. This cost estimation project can help health pol...

    Authors: Hosein Dalili, Mohaddese Fallahi, Saeid Moradi, Fatemeh Nayeri, Mamak Shariat and Arash Rashidian
    Citation: Health Economics Review 2014 4:21
  19. The introduction of the European Working Time Directive (EWTD) has greatly reduced training hours of surgical residents, which translates into 30% less surgical and clinical experience. Such a dramatic drop in...

    Authors: Simon Schimmack, Ulf Hinz, Andreas Wagner, Thomas Schmidt, Hendrik Strothmann, Markus W Büchler and Hubertus Schmitz-Winnenthal
    Citation: Health Economics Review 2014 4:14
  20. To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen
    Citation: Health Economics Review 2014 4:9

Annual Journal Metrics

  • 2022 Citation Impact
    2.4 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.204 - SNIP (Source Normalized Impact per Paper)
    0.836 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    220 days submission to accept (Median)

    2023 Usage 
    483 Altmetric mentions